Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker

The Multi-Ethnic Study of Atherosclerosis

Eve Marie A. Benson, Martin Tibuakuu, Di Zhao, Akintunde O. Akinkuolie, James D. Otvos, Daniel Duprez, David R Jacobs Jr, Samia Mora, Erin D. Michos

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Unhealthy lifestyles and inflammation contribute to cardiovascular disease (CVD). GlycA is a novel biomarker of systemic inflammation representing post-translational glycosylation of acute phase reactants and associated with increased clinical CVD risk. Hypothesis: We hypothesized that ideal cardiovascular health (CVH), as assessed by (higher) Life's Simple 7 (LS7) scores, would be associated with lower GlycA levels among individuals free of CVD in a multiethnic community-based population. Methods: This was a cross-sectional study of 6479 Multi-Ethnic Study of Atherosclerosis participants [53% women; mean age 62 ± 10 years] with GlycA levels measured at baseline by nuclear magnetic resonance spectroscopy. The LS7 metrics (smoking, physical activity, diet, body mass index, blood pressure, cholesterol, and glucose) were each scored as ideal (2), moderate (1), or poor (0). Total scores were summed and categorized as optimal (12-14), average (8-11), and inadequate (0-7). Linear regression assessed percent difference in GlycA by LS7 scores, after adjusting for age, sex, ethnicity, education, income, family history of CVD, and other inflammatory biomarkers. Results: GlycA levels were 403.4 ± 63.1, 374.4 ± 59.2, and 350.3 ± 56.2 micromoles per liter (μmol/L) for inadequate, average, and optimal CVH, respectively (P-trend <0.001). After multivariable adjustment, GlycA remained independently and inversely associated with CVH categories, with a lower mean GlycA level of 5 μmol/L (95% confidence interval 4.5-5.8) for each one unit increment in LS7 score. Conclusions: Among this group of ethnically diverse individuals without CVD, suboptimal CVH is associated with higher GlycA levels, independent of traditional inflammatory biomarkers. Strategies aimed at improving CVH might reduce GlycA, which could be a marker of reduced risk of future CVD events.

Original languageEnglish (US)
Pages (from-to)1439-1445
Number of pages7
JournalClinical Cardiology
Volume41
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Atherosclerosis
Cardiovascular Diseases
Health
Biomarkers
Inflammation
Social Adjustment
Sex Education
Acute-Phase Proteins
Glycosylation
Blood Glucose
Life Style
Linear Models
Body Mass Index
Magnetic Resonance Spectroscopy
Cross-Sectional Studies
Smoking
Cholesterol
Confidence Intervals
Exercise
Diet

Keywords

  • GlycA
  • cardiovascular health
  • inflammation
  • prevention

Cite this

Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker : The Multi-Ethnic Study of Atherosclerosis. / Benson, Eve Marie A.; Tibuakuu, Martin; Zhao, Di; Akinkuolie, Akintunde O.; Otvos, James D.; Duprez, Daniel; Jacobs Jr, David R; Mora, Samia; Michos, Erin D.

In: Clinical Cardiology, Vol. 41, No. 11, 01.11.2018, p. 1439-1445.

Research output: Contribution to journalArticle

Benson, Eve Marie A. ; Tibuakuu, Martin ; Zhao, Di ; Akinkuolie, Akintunde O. ; Otvos, James D. ; Duprez, Daniel ; Jacobs Jr, David R ; Mora, Samia ; Michos, Erin D. / Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker : The Multi-Ethnic Study of Atherosclerosis. In: Clinical Cardiology. 2018 ; Vol. 41, No. 11. pp. 1439-1445.
@article{030f553e64e64622b113d4802021f4e1,
title = "Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: The Multi-Ethnic Study of Atherosclerosis",
abstract = "Background: Unhealthy lifestyles and inflammation contribute to cardiovascular disease (CVD). GlycA is a novel biomarker of systemic inflammation representing post-translational glycosylation of acute phase reactants and associated with increased clinical CVD risk. Hypothesis: We hypothesized that ideal cardiovascular health (CVH), as assessed by (higher) Life's Simple 7 (LS7) scores, would be associated with lower GlycA levels among individuals free of CVD in a multiethnic community-based population. Methods: This was a cross-sectional study of 6479 Multi-Ethnic Study of Atherosclerosis participants [53{\%} women; mean age 62 ± 10 years] with GlycA levels measured at baseline by nuclear magnetic resonance spectroscopy. The LS7 metrics (smoking, physical activity, diet, body mass index, blood pressure, cholesterol, and glucose) were each scored as ideal (2), moderate (1), or poor (0). Total scores were summed and categorized as optimal (12-14), average (8-11), and inadequate (0-7). Linear regression assessed percent difference in GlycA by LS7 scores, after adjusting for age, sex, ethnicity, education, income, family history of CVD, and other inflammatory biomarkers. Results: GlycA levels were 403.4 ± 63.1, 374.4 ± 59.2, and 350.3 ± 56.2 micromoles per liter (μmol/L) for inadequate, average, and optimal CVH, respectively (P-trend <0.001). After multivariable adjustment, GlycA remained independently and inversely associated with CVH categories, with a lower mean GlycA level of 5 μmol/L (95{\%} confidence interval 4.5-5.8) for each one unit increment in LS7 score. Conclusions: Among this group of ethnically diverse individuals without CVD, suboptimal CVH is associated with higher GlycA levels, independent of traditional inflammatory biomarkers. Strategies aimed at improving CVH might reduce GlycA, which could be a marker of reduced risk of future CVD events.",
keywords = "GlycA, cardiovascular health, inflammation, prevention",
author = "Benson, {Eve Marie A.} and Martin Tibuakuu and Di Zhao and Akinkuolie, {Akintunde O.} and Otvos, {James D.} and Daniel Duprez and {Jacobs Jr}, {David R} and Samia Mora and Michos, {Erin D.}",
year = "2018",
month = "11",
day = "1",
doi = "10.1002/clc.23069",
language = "English (US)",
volume = "41",
pages = "1439--1445",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker

T2 - The Multi-Ethnic Study of Atherosclerosis

AU - Benson, Eve Marie A.

AU - Tibuakuu, Martin

AU - Zhao, Di

AU - Akinkuolie, Akintunde O.

AU - Otvos, James D.

AU - Duprez, Daniel

AU - Jacobs Jr, David R

AU - Mora, Samia

AU - Michos, Erin D.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Background: Unhealthy lifestyles and inflammation contribute to cardiovascular disease (CVD). GlycA is a novel biomarker of systemic inflammation representing post-translational glycosylation of acute phase reactants and associated with increased clinical CVD risk. Hypothesis: We hypothesized that ideal cardiovascular health (CVH), as assessed by (higher) Life's Simple 7 (LS7) scores, would be associated with lower GlycA levels among individuals free of CVD in a multiethnic community-based population. Methods: This was a cross-sectional study of 6479 Multi-Ethnic Study of Atherosclerosis participants [53% women; mean age 62 ± 10 years] with GlycA levels measured at baseline by nuclear magnetic resonance spectroscopy. The LS7 metrics (smoking, physical activity, diet, body mass index, blood pressure, cholesterol, and glucose) were each scored as ideal (2), moderate (1), or poor (0). Total scores were summed and categorized as optimal (12-14), average (8-11), and inadequate (0-7). Linear regression assessed percent difference in GlycA by LS7 scores, after adjusting for age, sex, ethnicity, education, income, family history of CVD, and other inflammatory biomarkers. Results: GlycA levels were 403.4 ± 63.1, 374.4 ± 59.2, and 350.3 ± 56.2 micromoles per liter (μmol/L) for inadequate, average, and optimal CVH, respectively (P-trend <0.001). After multivariable adjustment, GlycA remained independently and inversely associated with CVH categories, with a lower mean GlycA level of 5 μmol/L (95% confidence interval 4.5-5.8) for each one unit increment in LS7 score. Conclusions: Among this group of ethnically diverse individuals without CVD, suboptimal CVH is associated with higher GlycA levels, independent of traditional inflammatory biomarkers. Strategies aimed at improving CVH might reduce GlycA, which could be a marker of reduced risk of future CVD events.

AB - Background: Unhealthy lifestyles and inflammation contribute to cardiovascular disease (CVD). GlycA is a novel biomarker of systemic inflammation representing post-translational glycosylation of acute phase reactants and associated with increased clinical CVD risk. Hypothesis: We hypothesized that ideal cardiovascular health (CVH), as assessed by (higher) Life's Simple 7 (LS7) scores, would be associated with lower GlycA levels among individuals free of CVD in a multiethnic community-based population. Methods: This was a cross-sectional study of 6479 Multi-Ethnic Study of Atherosclerosis participants [53% women; mean age 62 ± 10 years] with GlycA levels measured at baseline by nuclear magnetic resonance spectroscopy. The LS7 metrics (smoking, physical activity, diet, body mass index, blood pressure, cholesterol, and glucose) were each scored as ideal (2), moderate (1), or poor (0). Total scores were summed and categorized as optimal (12-14), average (8-11), and inadequate (0-7). Linear regression assessed percent difference in GlycA by LS7 scores, after adjusting for age, sex, ethnicity, education, income, family history of CVD, and other inflammatory biomarkers. Results: GlycA levels were 403.4 ± 63.1, 374.4 ± 59.2, and 350.3 ± 56.2 micromoles per liter (μmol/L) for inadequate, average, and optimal CVH, respectively (P-trend <0.001). After multivariable adjustment, GlycA remained independently and inversely associated with CVH categories, with a lower mean GlycA level of 5 μmol/L (95% confidence interval 4.5-5.8) for each one unit increment in LS7 score. Conclusions: Among this group of ethnically diverse individuals without CVD, suboptimal CVH is associated with higher GlycA levels, independent of traditional inflammatory biomarkers. Strategies aimed at improving CVH might reduce GlycA, which could be a marker of reduced risk of future CVD events.

KW - GlycA

KW - cardiovascular health

KW - inflammation

KW - prevention

UR - http://www.scopus.com/inward/record.url?scp=85057008369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057008369&partnerID=8YFLogxK

U2 - 10.1002/clc.23069

DO - 10.1002/clc.23069

M3 - Article

VL - 41

SP - 1439

EP - 1445

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 11

ER -